ASIA-PACIFIC STEM CELL MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

ASIA-PACIFIC STEM CELL MARKET 2021-2028

Market by Therapeutic Application, Technology, Treatment Type, Product, Application, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The Asia-Pacific market for stem cell is likely to exhibit growth at 8.14% of CAGR during the evaluated years 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries reviewed in this market include:

•        India

•        China

•        Japan

•        Australia & New Zealand

•        South Korea

•        ASEAN countries

•        Rest of APAC

In China, the stem cell market is growing rapidly, owing to the government’s increasing efforts in strengthening the biotech industry. For instance, in 2019, the government granted 18 billion to biotechnology research under its five-year plan. Moreover, the regulatory framework for stem cell research, continual modernization of the healthcare sector, and rising public and private initiatives to influence the use of stem cell treatments, are also motivating the development of the studied market.

Furthermore, advancement in the concentration on clinical research, technological developments, regenerative medicines, and rising chronic diseases are another set of factors fueling the expansion of the stem cell market across China.

In India, the stem cell market is driven primarily due to multiple factors, including the high demand for regenerative treatment alternatives. The surge in the awareness about the importance of stem cell therapies in treating terminal conditions is also majorly influencing the studied market’s expansion. Additionally, numerous companies associated with stem cells are extending their business operations in the region. For instance, the Global Institute of Stem Cell Therapy and Research inaugurated a stem cell/ cancer research therapy center in Chandigarh. Hence, the increasing privatization, along with awareness about stem cell therapies are likely to augment the stem cell market in India.

Takara Holdings is a biotechnology company conducting business through different segments, such as gene therapy, Agri-bio, and bio industry. It provides its clientele with health foods, gene and cell therapies, raw alcohol, and seasonings, among others, via its subsidiaries. Moreover, its products are widely used for application in regenerative medicine research, along with the estimated candidate substance of the drugs. The company has its operations spread across various regions, with its headquarter set in Japan. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    ASIA-PACIFIC STEM CELL MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1.   THREAT OF NEW ENTRANTS

2.1.2.   THREAT OF SUBSTITUTE PRODUCTS

2.1.3.   BARGAINING POWER OF BUYERS

2.1.4.   BARGAINING POWER OF SUPPLIERS

2.1.5.   COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON STEM CELL MARKET

2.3. KEY IMPACT ANALYSIS

2.4. INDUSTRY COMPONENTS

2.5. LEGAL, POLICY, & REGULATORY FRAMEWORK

2.6. MARKET ATTRACTIVENESS INDEX

2.7. VENDOR SCORECARD

2.8. KEY INSIGHTS

2.9. MARKET DRIVERS

2.9.1.   GROWING AWARENESS ABOUT UMBILICAL CORD STEM CELLS

2.9.2.   SURGE IN STEM CELL RESEARCH AND DEVELOPMENT

2.9.3.   RISING DEMAND FOR REGENERATIVE MEDICINE

2.10.  MARKET RESTRAINTS

2.10.1.    ETHICAL CONCERNS ASSOCIATED WITH STEM CELLS

2.10.2.     HIGH COST OF STEM CELL PROCEDURES

2.10.3.     STRINGENT REGULATIONS IN TERMS OF STEM CELL THERAPY

2.11.  MARKET OPPORTUNITIES

2.11.1.     ADVANCEMENT IN TECHNOLOGY

2.11.2.     RISK OF ADVERSE IMMUNE REACTIONS AND COMPLICATIONS

3.    ASIA-PACIFIC STEM CELL MARKET OUTLOOK - BY THERAPEUTIC APPLICATION

3.1. NEUROLOGICAL DISORDERS

3.2. ONCOLOGY DISORDERS

3.3. DIABETES

3.4. INJURIES AND WOUNDS

3.5. ORTHOPEDIC TREATMENTS

3.6. CARDIOVASCULAR DISORDERS

3.7. OTHER THERAPEUTIC APPLICATIONS

4.    ASIA-PACIFIC STEM CELL MARKET OUTLOOK - BY TECHNOLOGY

4.1. CRYOPRESERVATION

4.2. ACQUISITION

4.2.1.   STEM CELL APHERESIS

4.2.2.   STEM CELL BONE MARROW MARKET

4.2.3.   STEM CELL UMBILICAL CORD

4.3. EXPANSION AND SUB-CULTURE

4.4. PRODUCTION

4.4.1.   STEM CELL CULTURE

4.4.2.   THERAPEUTIC CLONING

4.4.3.   IVF

5.    ASIA-PACIFIC STEM CELL MARKET OUTLOOK - BY TREATMENT TYPE

5.1. ALLOGENEIC STEM CELL THERAPY

5.2. AUTOLOGIC STEM CELL THERAPY

5.3. SYNGENEIC STEM CELL THERAPY

6.    ASIA-PACIFIC STEM CELL MARKET OUTLOOK - BY PRODUCT

6.1. ADULT STEM CELL

6.1.1.   HEMATOPOIETIC STEM CELL

6.1.2.   NEURAL STEM CELL

6.1.3.   UMBILICAL CORD STEM CELL

6.1.4.   MESENCHYMAL STEM CELL

6.1.5.   DENTAL STEM CELL

6.2. HUMAN EMBRYONIC STEM CELL

6.3. PLURIPOTENT

6.4. MOUSE/RAT NEURAL

7.    ASIA-PACIFIC STEM CELL MARKET OUTLOOK - BY APPLICATION

7.1. REGENERATIVE MEDICINE

7.2. DRUG DISCOVERY AND DEVELOPMENT

8.    GEOGRAPHICAL ANALYSIS - ASIA PACIFIC

8.1. COUNTRY ANALYSIS

8.1.1.   CHINA

8.1.2.   JAPAN

8.1.3.   INDIA

8.1.4.   AUSTRALIA & NEW ZEALAND

8.1.5.   SOUTH KOREA

8.1.6.   ASEAN COUNTRIES

8.1.7.   REST OF ASIA-PACIFIC

9.    COMPANY PROFILES

9.1. CORNING INC

9.2. STEMCELL TECHNOLOGIES

9.3. STRYKER CORPORATION

9.4. BECTON DICKINSON AND COMPANY (BD)

9.5. CYTORI THERAPEUTICS

9.6. QIAGEN NV

9.7. GE HEALTHCARE

9.8. TAKARA HOLDINGS

9.9. SMITH & NEPHEW PLC

9.10. INTERNATIONAL STEM CELL CORP

9.11. MILTENYI BIOTEC

9.12.  MERCK KGAA (SIGMA ALDRICH)

9.13. THERMO FISHER SCIENTIFIC INC

9.14.  ALLCELLS LLC

9.15. PLURISTEM THERAPEUTICS INC

10. RESEARCH METHODOLOGY & SCOPE

10.1.  RESEARCH SCOPE & DELIVERABLES

10.1.1.    OBJECTIVES OF STUDY

10.1.2.     SCOPE OF STUDY

10.2.  SOURCES OF DATA

10.2.1.    PRIMARY DATA SOURCES

10.2.2.     SECONDARY DATA SOURCES

10.3.   RESEARCH METHODOLOGY

10.3.1.     EVALUATION OF PROPOSED MARKET

10.3.2.      IDENTIFICATION OF DATA SOURCES

10.3.3.      ASSESSMENT OF MARKET DETERMINANTS

10.3.4.       DATA COLLECTION

10.3.5.       DATA VALIDATION & ANALYSIS

List of table

TABLE 1        ASIA-PACIFIC STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2        VENDOR SCORECARD

TABLE 3        ASIA-PACIFIC STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 4        ASIA-PACIFIC STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 5        ASIA-PACIFIC ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6        ASIA-PACIFIC PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 7        ASIA-PACIFIC STEM CELL MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)

TABLE 8        ASIA-PACIFIC STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 9        ASIA-PACIFIC ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 10      ASIA-PACIFIC STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 11      ASIA-PACIFIC STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1      ASIA-PACIFIC STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 2      ASIA-PACIFIC STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 3      ASIA-PACIFIC STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 4      ASIA-PACIFIC STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION)

FIGURE 5      ASIA-PACIFIC STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)

FIGURE 6      ASIA-PACIFIC STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)

FIGURE 7      ASIA-PACIFIC STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 8      ASIA-PACIFIC STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 9      ASIA-PACIFIC STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)

FIGURE 10   ASIA-PACIFIC STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION)

FIGURE 11   ASIA-PACIFIC STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)

FIGURE 12   ASIA-PACIFIC STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)

FIGURE 13   ASIA-PACIFIC STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)

FIGURE 14   ASIA-PACIFIC STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)

FIGURE 15   ASIA-PACIFIC STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION)

FIGURE 16   ASIA-PACIFIC STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION)

FIGURE 17   ASIA-PACIFIC STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)

FIGURE 18   ASIA-PACIFIC STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION)

FIGURE 19   ASIA-PACIFIC STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 20   ASIA-PACIFIC STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 21   ASIA-PACIFIC STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 22   ASIA-PACIFIC STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 23   ASIA-PACIFIC STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 24   ASIA-PACIFIC STEM CELL MARKET, BY NEURAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 25   ASIA-PACIFIC STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 26   ASIA-PACIFIC STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 27   ASIA-PACIFIC STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 28   ASIA-PACIFIC STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)

FIGURE 29   ASIA-PACIFIC STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION)

FIGURE 30   ASIA-PACIFIC STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)

FIGURE 31   ASIA-PACIFIC STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 32   ASIA-PACIFIC STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)

FIGURE 33   CHINA STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 34   JAPAN STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 35   INDIA STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 36   AUSTRALIA & NEW ZEALAND STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 37   SOUTH KOREA SURGICAL STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 38   ASEAN COUNTRIES STEM CELL MARKET 2021-2028 (IN $ MILLION)

FIGURE 39   REST OF ASIA-PACIFIC STEM CELL MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;